within Pharmacolibrary.Drugs.L_AntineoplasticAndImmunomodulatingAgents.L01B_Antimetabolites.L01BB06_Clofarabine;

model Clofarabine
  extends Pharmacolibrary.Drugs.ATC.L.L01BB06;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>L01BB06</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Clofarabine is a purine nucleoside antimetabolite used primarily in the treatment of relapsed or refractory acute lymphoblastic leukemia (ALL) in pediatric patients. It is also used off-label for other hematologic malignancies. Clofarabine is approved for use in several countries for specific indications.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters derived from pediatric patients (ages 1–21 years) with relapsed or refractory ALL after intravenous infusion.</p><h4>References</h4><ol><li><p>Bonate, PL, et al., &amp; Weitman, S (2011). Population pharmacokinetics of clofarabine and its metabolite 6-ketoclofarabine in adult and pediatric patients with cancer. <i>Cancer chemotherapy and pharmacology</i> 67(4) 875–890. DOI:<a href=&quot;https://doi.org/10.1007/s00280-010-1376-z&quot;>10.1007/s00280-010-1376-z</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/20582417/&quot;>https://pubmed.ncbi.nlm.nih.gov/20582417</a></p></li><li><p>Long-Boyle, J, et al., &amp; Jacobson, P (2011). Pharmacokinetics of clofarabine in patients with high-risk inherited metabolic disorders undergoing brain-sparing hematopoietic cell transplantation. <i>Journal of clinical pharmacology</i> 51(5) 679–686. DOI:<a href=&quot;https://doi.org/10.1177/0091270010372519&quot;>10.1177/0091270010372519</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/20525919/&quot;>https://pubmed.ncbi.nlm.nih.gov/20525919</a></p></li><li><p>Berg, SL, et al., &amp; Blaney, SM (2005). Plasma and cerebrospinal fluid pharmacokinetics of clofarabine in nonhuman primates. <i>Clinical cancer research : an official journal of the American Association for Cancer Research</i> 11(16) 5981–5983. DOI:<a href=&quot;https://doi.org/10.1158/1078-0432.CCR-05-0261&quot;>10.1158/1078-0432.CCR-05-0261</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/16115942/&quot;>https://pubmed.ncbi.nlm.nih.gov/16115942</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Clofarabine;
